Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
2.410
+0.020 (0.83%)
Aug 8, 2025, 10:36 AM - Market open
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $67.12 million as of August 8, 2025. Its market cap has increased by 21.00% in one year.
Market Cap
67.12M
Enterprise Value
51.70M
1-Year Change
21.00%
Ranking
Category
Stock Price
$2.41
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $67.12M, an increase of 2.10%. That is a compound annual growth rate of 0.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 66.57M | 10.00% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.55B |
| Johnson & Johnson | 411.03B |
| AbbVie | 349.12B |
| Abbott Laboratories | 229.25B |
| AstraZeneca | 228.71B |
| Novartis AG | 221.76B |
| UnitedHealth Group | 218.07B |
| Novo Nordisk | 200.63B |